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SUMMARY (limit = 250 words, currently = 239) 
 
Lysergic acid diethylamide (LSD) is a non-selective serotonin-receptor agonist that was first 
synthesized in 1938 and identified as (potently) psychoactive in 1943. Psychedelics have been used 
by indigenous cultures for millennia [1]; however, because of LSD’s unique potency and the timing of 
its discovery (coinciding with a period of major discovery in psychopharmacology), it is generally 
regarded as the quintessential contemporary “psychedelic” [2]. LSD has profound modulatory effects 
on consciousness and was used extensively in psychological research and psychiatric practice in the 
1950s and 60s [3]. In spite of this, however, there have been no modern human imaging studies on its 
acute effects on the brain. Here we studied the effects of LSD on intrinsic functional connectivity within 
the human brain using functional MRI (fMRI). High-level association cortices (partially overlapping with 
the default mode, salience and frontoparietal attention networks) and the thalamus showed increased 
global connectivity under the drug. The cortical areas showing increased global connectivity 
overlapped significantly with a map of serotonin 2A receptor densities (the key site of action of 
psychedelic drugs [4]). LSD also increased global integration by inflating the level of communication 
between normally distinct brain networks. The increase in global connectivity observed under LSD 
correlated with subjective reports of ego-dissolution. The present results provide the first evidence that 
LSD selectively expands global connectivity in the brain, compromising the brain’s modular and “rich-
club” organization and simultaneously the perceptual boundaries between the self and the 
environment.  
 
 
HIGHLIGHTS 
 High-level cortical regions and the thalamus show increased global connectivity under LSD. 
 The brain’s modular and rich-club organization is altered under LSD. 
 Increased global connectivity under LSD correlates with ego-dissolution scores.  
 
eTOC Blurb 
 
Tagliazucchi et al. found that increased global communication mediated by the brain’s key integration 
centres underlies the LSD-induced “ego-dissolution” experience. This globally enhanced integration 
impairs the functional identity of brain systems, leading to feelings of ego-dissolution and disturbed 
ego-boundaries.   
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RESULTS 
 
Functional magnetic resonance imaging (fMRI) was used to investigate global and local changes in 
functional connectivity following intravenous injection of LSD vs. placebo to fifteen healthy volunteers. 
The experiment followed a randomized and balanced within-subject design and both whole-brain 
“exploratory” and more selective “hypothesis-driven” data-analysis approaches were employed. Based 
on the predominantly cortical distribution of 5-HT2A receptors [5, 6] (the principal receptor mediating 
psychedelic effects [4]), as well as previous findings with other psychedelics [5, 7, 8], we 
hypothesised that connectivity changes would implicate high-level cortical networks such as the 
default-mode network (DMN) [9] and salience network [10]. The association between these networks 
and self-consciousness [7, 11, 12] led us to expect a parametric correlation with the intensity of 
subjective reports of ego-dissolution under LSD, i.e. a compromised sense of possessing an 
integrated and distinct personality or identity. 
 
We first studied changes in the overall connectivity of 401 even-sized regions of interest (ROI) 
completely covering cortical and sub-cortical grey matter and obtained using a method introduced by 
Zalesky and colleagues [13]. We computed the functional connectivity density (FCD) [14] as the 
average correlation between the spontaneously fluctuating Blood Oxygenation Level Dependent 
(BOLD) signal at each region of interest and the time series from all remaining ROIs. Thus, high FCD 
values correspond to regions whose activity is strongly correlated to that of the rest of the brain, 
whereas activity in regions with low FCD values  is weakly correlated to that of the rest of the brain. 
The average FCDs measured under LSD and placebo are shown in Figure 1A as a 3D rendering on 
top of a grey matter surface. Histograms depicting the distribution of FCD values across all ROIs were 
obtained for both conditions. In the LSD condition there was a tail of highly coupled regions that was 
less prominent in the placebo condition (Figure 1B). FCD values were globally increased under LSD 
compared with placebo (inset of Figure 1B).  
 
The increases in global connectivity under LSD were observed in predominantly in frontal, parietal and 
inferior temporal cortices, as well as in the bilateral thalamus. In Figure 1C we present a rendering of 
these effects together with the outline of three resting state networks (RSN) obtained by applying 
independent component analysis [15] to resting state data from 35 healthy subjects in the Human 
Connectome Project (HCP) data-set (http://www.humanconnectomeproject.org/). These three RSN 
(bilateral fronto-parietal, default mode and salience networks) showed a significant overlap with FCD 
increases under LSD (Figure 1D) and have been implicated in the action of other psychedelics [5, 8]. 
Additionally, we found a significant overlap between FCD increases under LSD and the distribution of 
5-HT2A receptors obtained using PET [6] (the key site of action of psychedelic drugs [4]), as well as 
with FCD increases observed under psilocybin (same data and preprocessing as reported in [16]) 
(Figure 1D, right). We did not observe significant overlap between FCD increases and the distribution 
of other serotonin receptors (5-HT1A and 5-HT1B). 
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Subsequently, we correlated the magnitude of regional FCD increases observed under LSD with the 
intensity of ego-dissolution reported by the participants (LSD minus placebo) across all regions of 
interest. Regions surviving correction for multiple comparisons included the bilateral temporo-parietal 
junction (angular gyrus) and the bilateral insular cortex (red rendering in Figure 2A). The specificity of 
this finding was assessed by also correlating all other VAS scores with FCD increases under LSD. 
Importantly, ego-dissolution was the only subjective rating that survived this multiple comparisons 
correction (see Figure S2 for more information on VAS and ASC scores). In the green rendering in 
Figure 2A, we identify those regions presenting correlations with ego-dissolution scores (corrected for 
multiple comparisons) and uncorrelated to all other VAS scores (at a level p<0.05, uncorrected). 
Scatter plots of FCD vs. ego-dissolution are shown in Figure 2B for four example regions located in 
the left/right angular gyrus and insula. These regions were selected based on their overlap with the 
corresponding Automated Anatomical Labeling (AAL) atlas regions, and due to their association with 
self-awareness [11, 12, 36, 37]. Scatter plots of FCD vs. the other five VAS scores are provided in 
Figure S4 and plots for four additional regions are provided in Figure S3. 
 
The FCD increases indicated that the overall “global” connectivity of the regions in Figure 1C 
increased under LSD relative to placebo. Next, we asked which areas of the brain became especially 
more engaged with these highly globally connected brain areas under LSD. To do this, we divided the 
FCD difference map (Figure 1C) into four components: a frontal seed (comprising parts of inferior, 
middle and superior frontal gyri); a parietal seed (bilateral temporo-parietal junction/angular gyrus); the 
precuneus and the bilateral thalamus. Seed-based regression analyses were subsequently conducted 
based on each of these four seeds (as the independent variables) with the total 401 ROIs as 
dependent variables. Figure 3 displays difference maps with the regions becoming more connected 
coupled with four FCD-determined seeds (left panel) under LSD relative to placebo. In all four cases, 
sensory cortices were implicated (right panel). This result was further confirmed by repeating the 
permutation analysis [16] conducted for the FCD map (Figure 1D) - yielding a significant overlap 
between the difference maps and four HCP-derived RSNs: a sensorimotor RSN spanning the pre- and 
post-central gyri, two visual RSN (medial and lateral) and an auditory RSN encompassing the superior 
temporal cortex (including the primary auditory cortex in the Heschl's gyrus). For comparison, the 
contour of these RSN is overlaid with the maps of statistically significant regions in Figure 3 (right 
panel). 
 
Next, we evaluated whether LSD only scaled the magnitude of the coupling or also re-arranged 
connectivity patterns in the brain, independently of the coupling strength. To do this, we studied the 
modularity of whole-brain functional connectivity networks having the ROIs as nodes. In the present 
context, modularity measures how well the brain can be parcellated into modules having dense within-
module and sparse between-module connectivity [17]. Based on the observation of increased 
between-network connectivity under LSD (Figure 3), as well as previous findings with other 
psychedelics [18], we predicted that there would be a decrease in brain modularity under the drug, 
indicating a reduction in the separation of intrinsic brain networks.  As shown in Figure 4A, this 
prediction was supported over an extended range of functional network link densities (ratio of the 
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number of binary connections present in the network to the maximum possible number of connections; 
see methods). In Figure 4B, we show the modules identified by the modularity optimization algorithm. 
We also computed the participation coefficient of each node (measuring how much each node 
communicates across modules relative to how much they communicate within their own module [17]) 
and observed increased participation coefficients in frontal and midline regions (Figure 4C) 
overlapping with those in Figure. 1C, suggesting that these areas serve as conduits for increased 
between-module communication under LSD.  
 
Finally, we investigated changes in the level of integration between highly coupled regions by means 
of the so called “rich club” coefficient Φ(k). This metric calculates the ratio of links between nodes of 
degree (i.e. number of attached links) higher than a certain number (k) over the maximum possible 
number of links between them, and it is normalized by the same metric computed after degree-
preserving randomization of the network [19]. In Figure 4D we show that the rich club coefficient is 
higher under placebo than LSD, indicating that LSD decreases the level of (preferential) 
communication between the brain’s dominant hub regions. These hub regions are found within a 
single module (corresponding to primary sensory areas, green module in Figure 4B) as revealed by 
the k-core of the LSD and placebo networks (with k=100), defined as the smallest subset of nodes 
with degree at least equal to k (see Figure 4E). Thus, LSD enhances between-module integration at 
the expense of impairing within-module communication of highly coupled nodes. 
 
 
DISCUSSION 
Taken together, the present results indicate that LSD enhances global and between-module 
communication while diminishing the integrity of individual modules and that this effect is mediated by 
the brain’s key integration centres such as those that are rich in serotonin 2A receptors. These results 
invite comparisons with those of our previous  functional imaging studies with psilocybin, a related 
compound and another serotonergic psychedelic. For example, in [5] we reported decreases in 
functional connectivity between anterior and posterior nodes of the DMN under psilocybin, and in 
Carhart-Harris et al., 2014 [20] and Muthukumaraswamy et al., 2013 [21] we suggested that 
decreased within-network integrity was a general property of psychedelics. Furthermore, two  
subsequent reports detailed increased between-RSN connectivity under psilocybin [18, 22], matching 
the directionality of the effects found here with LSD. Indeed, re-analysis of our previously-acquired 
psilocybin fMRI data revealed FCD increases in regions similar to those observed here with LSD 
(Figures 1D and S1). Importantly, despite overlap with the default mode, frontoparietal and salience 
networks, the results of the current FCD analysis were not constrained a priori to these or any other 
specific RSN.  
 
Intriguingly, a formal analysis revealed significant overlap between the regions of increased global 
connectivity under LSD and those that express the serotonin 2A receptors in especially high 
concentrations. Serotonin 2A receptor agonism is known to increase cell excitability (in particular that 
of layer V pyramidal neurons) [23], which may result in higher metabolic demands. Increased glucose 
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metabolism in frontal, temporal and subcortical regions was reported for serotonergic psychedelics 
and these increases correlated with subjective reports of ego-dissolution [24]. Glucose metabolism is 
also known to covariate with the density of functional connections [25], thus establishing a possible 
connection between the FCD increases observed here and 5-HT2A-mediated changes in neural 
excitability.  
 
Electroencephalography studies performed during the 1950s and 1960s reported broadband 
decreases in oscillatory power under LSD [26] and magnetoencephalography recently revealed 
diminished power in a broad range of frequency bands after psilocybin infusion [21]. Serotonin 2A 
receptor-mediated oscillatory desynchronization can be traced to an uncoupling of layer 5 pyramidal 
cell firing from local field potential oscillations [27] – suggesting that dysregulating the firing of these 
neurons is critical. In the human cortex, decreases in alpha power after psilocybin infusion were 
particularly marked and decreased alpha in the posterior DMN (precuneus/posterior cingulate cortex) 
correlated with the intensity of ego-dissolution [20]. A number of multimodal EEG-fMRI studies have 
now revealed an inverse correlation between global functional connectivity and power in the alpha 
band [28, 29, 30], which reconciles these electrophysiological observations with our findings of 
increased global connectivity in high-level association areas with both LSD and psilocybin. Alpha 
oscillations have been hypothesized to inhibit or regulate task-irrelevant (i.e. “spontaneous” or “on-
going”) neural processes [31]; thus, findings of reduced-alpha under psychedelics suggest that these 
drugs could reduce this inhibition (i.e. be “disinhibitory”). It must be noted, however, that alpha 
oscillations are linked to a number of cognitive processes (e.g. attention, memory, executive control 
and conscious access) [32] and the hypothesised “disinhibition” cannot be directly inferred from the 
present results.  
 
The areas of the brain that displayed increased global connectivity under LSD have different functional 
roles. The fronto-parietal cortex is implicated in conscious information access [33] and its activity is 
suppressed in some states of diminished conscious awareness (such as seizures or deep sleep) [34], 
even though an unequivocal link between fronto-parietal activity and the conscious state is lacking. 
Different DMN components perform functions related to self-consciousness: activity in the precuneus 
correlates with self-reflection processes and autobiographical memory retrieval [35], while the 
activation of temporo-parietal junctions is typical of out-of-body experiences [36]. The bilateral insular 
cortex is related to self-awareness [37], as well as to the processing of emotional information [38], that 
could also play an important role in the psychedelic experience. One intriguing possibility is that 
increased cross talk between these networks and other brain systems underlies the experience of 
ego-dissolution under LSD. This scenario is supported by our observation of positive correlations 
between increased FCD in the bilateral temporo-parietal junction and insular cortex and subjective 
reports of ego-dissolution. Furthermore, we observed that the increases in global connectivity in these 
high-level regions particularly involved sensory areas. This increased communication between high-
level (association) and lower-level (sensory) cortices might represent a collapse in the normal 
hierarchical organization of the brain [20] such that the boundaries between lower level systems 
anchored to the external world and higher level systems operating more autonomously from sensory 
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information, become blurred. It is intriguing to speculate whether this blurring of boundaries and 
putative expansion of the “global workspace” [33] are related to the blurring of ego-boundaries and the 
experiences of ego-dissolution and “expanded awareness” reported in relation to psychedelics.  
 
It is deserving of mention that our exploratory imaging analysis revealed significant (corrected) 
correlations with only one (out of 6) VAS items, i.e. the one that enquired about feelings of ego-
dissolution. That the results of these exploratory, whole-brain analyses correlated selectively with ego-
dissolution may be significant, as it suggests that this phenomenon is important [7] and dependent on 
changes that implicate the whole of the brain rather than specific functional modules. It remains 
possible however that other aspects of the psychedelic experience (e.g. visual hallucinations) may 
depend on changes in the functioning of a particular module (e.g. the visual cortex) and this is 
something we intend to investigate in the future.  
 
As mentioned above, the quality of consciousness under psychedelics is frequently referred to as 
“expanded” [20]. It is reasonable to infer therefore, that the neurophysiology of the psychedelic state 
will contrast with that of states of “diminished consciousness”, such as deep sleep or under general 
anesthesia. Our results support this inference on many levels. As discussed above, increased fronto-
parietal FCD under LSD suggests higher metabolism in these regions, whereas unconscious states 
are generally characterized by diminished fronto-parietal metabolism and connectivity [34]. Deep 
sleep, for instance, presents decreased density and efficiency of fronto-parietal functional connections 
[39]. Both sleep and anesthesia are characterized by a breakdown of functional integration, resulting 
in increased modularity values [40, 41], whereas we observed decreased modularity values under 
LSD, reflecting enhanced between-module cross-talk. Broadly speaking, this study's results are 
consistent with the previous hypothesis that the psychedelic and unconscious states occupy polar-
opposite ends of a spectrum of conscious states, defined by their level of entropy or randomness [20]. 
This hypothesis can now be updated to state that the brain's level of modularity (low modularity being 
characteristic of random and disordered networks [17]), during a particular period of time (e.g. the 
duration of resting-state scan), is predictive of the subjective quality of consciousness that is 
experienced during that period. Further work is required to develop our characterization and 
subsequent quantification of the subjective nature of conscious states [42]; however, the present 
measure of ego-dissolution can be viewed as a start in this direction.  
 
Some limitations of our study must be acknowledged. First, while we attempted by all available means 
to reduce the impact of head motion in our results and to show that our results cannot be attributed to 
motion confounds (see “Motion” section in the supplemental experimental procedures), significant 
differences in head motion persisted between conditions. Second, the particularly strict criteria used to 
combat motion artefacts reduced our original sample of 20 subjects to a smaller sample of 15 “clean” 
datasets. Third, our analysis of ego-dissolution was based on a single numerical report by 
experienced psychedelic drug users; future studies should attempt a more thorough characterization 
of the subjective dimension of this experience. Finally, since the participants were experienced 
psychedelic drug users it is more likely they could differentiate the LSD from the placebo, potentially 
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leading to demand characteristics. It would be interesting to repeat these analyses in psychedelic-
naïve participants to test whether past-use of psychedelics can be predictive of the reported effects, 
although we failed to observe any correlations between past-use and the above-reported effects of 
LSD in the present study.   
 
In conclusion, the present study aimed to explore one of the most remarkable and least understood 
domains of the psychedelic experience, known both colloquially and academically as “ego-
dissolution”. It revealed an increase in global integration within the brain (but a decrease in within-
module integrity), seemingly mediated by high-level cortical association regions that are rich in 
serotonin 2A receptors as well as the thalamus. Importantly, the increases in global integration in 
cortical association regions selectively correlated with subjective ratings of ego-dissolution. These 
results help to inform not just on the neurobiology of the psychedelic experience but on a fundamental 
aspect of human consciousness, namely the sense of possessing a coherent “self” or “ego” that is 
distinct from others and separate from the external environment. Further work is required to develop 
these insights and explore other interesting aspects of the phenomenology of the psychedelic 
experience. Finally, the present study reinforces the view that, conducted with appropriate care, 
human research with psychedelic drugs is safe and can provide valuable insights in human 
neuroscience.   
 
EXPERIMENTAL PROCEDURES 
 
The experimental procedures (including information on subject recruitment, experimental design, data 
acquisition and data analysis) are provided in the supplemental information. 
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FIGURE CAPTIONS 
 
Figure 1. LSD selectively increases global functional connectivity of higher-level integrative 
cortical and sub-cortical regions. (A) Average FCD under the placebo and LSD conditions. (B) 
Normalized histogram (P) of all FCD values for both conditions (mean ± SEM). The inset shows the 
whole-brain FCD averages (*p<0.05, two-tailed t-test). (C) Rendering of significant FCD increases 
under LSD vs. placebo (thresholded at p<0.05, two-tailed t-test, FDR-controlled for multiple 
comparisons). Outlines of the bilateral fronto-parietal, salience and default-mode RSN are overlaid on 
top of the map of FCD significant increases. (D) Quantitative analysis of the overlap between 
significant FCD increases and eight RSN obtained from 35 subjects scanned in the Human 
Connectome Project (FP=fronto-parietal, Sal=salience, DMN=default mode, Vis L=lateral visual, 
Aud=auditory, Vis M=medial visual, SM=sensorimotor), as well as 5-HT2A receptor concentration and 
FCD increases under psilocybin. Only FP, DMN, Sal, and the maps of 5-HT2A concentration and FCD 
increases under psilocybin had an overlap significantly higher than the one observed when spatially 
randomizing the networks (mean ± SD, *p<0.05, Bonferroni corrected for multiple comparisons). For a 
description of the randomization procedure see [16] and the Supp. Info. 
 
Figure 2. FCD increases correlate with subjective reports of ego-dissolution. (A) Brain regions 
where a significant (p<0.05, two-tailed, FDR-controlled for multiple comparisons) correlation between 
FCD and subjective reports of ego-dissolution (LSD minus placebo) was found are colored in red. 
Brain regions where none of the other VAS scores correlated with FCD at p<0.05, two-tailed, 
uncorrected (i.e. regions presenting the most selective correlations between FCD increases and ego-
dissolution scores)  are colored in green. (B) Association between FCD increases and reports of ego-
dissolution in four example ROIs (bilateral angular gyrus and insular cortex). 
 
Figure 3. LSD increases between-system functional connectivity. Results of seed correlation 
analyses based on four ROIs (left panel) defined from the map of significant FCD increases (Figure 
1C). In the right panel, regions in red indicate significantly higher connectivity (p<0.05, two-tailed t-test, 
FDR-controlled for multiple comparisons) with the seed (first column, in blue) under LSD relative to the 
placebo. A permutation test revealed that only four RSN present a significant (p<0.05, Bonferroni 
corrected for multiple comparisons) overlap with the functional connectivity increases under LSD: the 
sensorimotor (SM), auditory (Aud), visual medial (Vis M) and visual lateral (Vis L) RSNs.  The contour 
of these RSN is jointly rendered with the maps of functional connectivity changes. 
 
Figure 4. LSD increases global integration. (A) Modularity vs. link density for the LSD and placebo 
conditions (mean ± SEM, *p<0.05, two-tailed t-test, FDR-controlled for multiple comparisons). The 
inset shows the same for networks after degree-preserving randomization (no significant differences 
were found). (B) Rendering of the modules identified at a reference link density of 0.3, for the placebo 
(up) and LSD (bottom) conditions. (C) Regions presenting increased participation coefficient in LSD 
vs. placebo (link density = 0.3, p<0.05 two-tailed t-test, FDR-controlled for multiple comparisons). (D) 
13 
Normalized rich club coefficient ϕ(k) for LSD and placebo; the inset shows the difference between 
both conditions (mean ± SEM, link density = 0.3, *p<0.05, two-tailed t-test, FDR-controlled for multiple 
comparisons). (E) k-cores (k = 100) for placebo (up) and LSD (bottom) conditions. 
Figure Click here to download Figure fig1.jpg 
Figure Click here to download Figure fig2.jpg 
Figure Click here to download Figure fig3.jpg 
Figure Click here to download Figure fig4.jpg 
 
Supplemental Figures and Legends 
 
 
 
 
 
Figure S1: Psilocybin selectively increases global functional connectivity of higher-level integrative 
cortical and sub-cortical regions, and increases between-system functional connectivity. (A) Average 
FCD under the placebo and psilocybin conditions. (B) Rendering of significant FCD increases under 
psilocybin vs. placebo (thresholded at p<0.05, FDR-controlled for multiple comparisons). Subjects and 
data preprocessing is as reported in Tagliazucchi et al., 2014. (C) Regions for seed correlation analysis 
(defined from the map of FCD increases in Panel B). (D) Results of seed correlation. Regions in red 
present significantly higher connectivity (p<0.05, FDR-controlled for multiple comparisons) with the 
seeds (panel C) under psilocybin compared with placebo. Subjects and data preprocessing is as 
reported in [S1]. 
 
  
Supplemental Data
 
Figure S2: (A) Average VAS scores for LSD (red) and placebo (blue) (mean ± SEM). (B) Average ASC 
scores for LSD (red) and placebo (blue) (mean ± SEM). Significance tested with the nonparametric 
Wilcoxon’s signed-rank test, Bonferroni correction for multiple comparisons applied. (C) Correlation 
between VAS scores across participants. (D) Correlation between ASC scores across participants. (E) 
Correlation between VAS scores and ASC scores across participants. For the full description of the VAS 
and ASC items see the corresponding subsections in the Supplemental Experimental Procedures. 
 
  
 
 
Figure S3: (A) Regions where a significant correlation between FCD increases and ego-dissolution 
scores was observed under LSD (p<0.05, FDR-corrected for multiple comparisons). For a description of 
the colour scheme, see the analogous Figure 2A in the manuscript text. (B) Scatter plots of ego-
dissolution changes under LSD (minus placebo) vs. FCD increases for four additional regions: left/right 
middle frontal gyrus (MFG) and left/right middle occipital gyrus (MOG). In the inset, Pearson’s R and the 
associated (uncorrected) p-values are provided. 
 
  
 
Figure S4: Scatter plots of FCD increases (LSD minus placebo) vs. VAS items: “Intensity”, “Simple 
hallucinations”, “Complex hallucinations”, “Emotional arousal” and “Positive mood”, for the regions 
presented in Figure 2B (Angular gyrus R/L and insula R/L). In the insets, the following statistics are 
provided. R: Pearson’s linear correlation coefficient between variables, pcorr: p-value for the correlation 
(FDR-controlled for multiple comparisons across all 401 regions in the template), p: uncorrected p-value 
for the correlation, z: z-values for the test of higher correlation between FCD increases and ego-
dissolution vs. FCD increases and other VAS items, p’: the p-value corresponding to the z-value. These 
z and p-values were obtained using the following web utility: http://quantpsy.org/corrtest/corrtest2.htm. 
For all except four of the comparisons we obtained p’<0.05, supporting the specificity of the correlations 
with ego-dissolution in this set of regions. Of those comparisons with p’>0.05, half of them corresponded 
to correlations with the “Intensity of the experience” item. This seems to indicate that feelings of ego-
dissolution carry the most weight when participants rate the intensity of their experience, also supported 
by the fact that, among all VAS items, “Intensity” presented the strongest correlations with “Ego-
dissolution” (Figure S2, panel C).  
 
  
 
 
Supplemental Experimental Procedures 
 
 
Subject recruitment and experimental design 
 
This study was approved by the National Research Ethics Service (NRES) committee London 
- West London, and was conducted in accordance with the revised declaration of Helsinki 
(2000), the International Committee on Harmonization Good Clinical Practice guidelines and 
the National Health Service (NHS) Research Governance Framework. Imperial College 
London sponsored the research, which was conducted under a Home Office license for 
research with schedule 1 drugs.  
 
Participants were recruited via word of mouth and provided written informed consent to 
participate after being screened for physical and mental health. The screening for physical 
health included electrocardiogram, routine blood tests, and urine test for recent drug use and 
pregnancy. A psychiatric interview was conducted with participants providing full disclosure of 
their drug use history. Key exclusion criteria included: < 21 years of age, personal history of 
diagnosed psychiatric illness, immediate family history of a psychotic disorder, an absence of 
previous experience with a classic psychedelic drug (e.g. LSD, mescaline, psilocybin/magic 
mushrooms or DMT/ayahuasca), psychedelic drug use within 6 weeks of the first scanning 
session, pregnancy, problematic alcohol use (i.e. > 40 units consumed per week), or a 
medically significant condition rendering the volunteer unsuitable for the experimental 
environment. Before intravenous LSD infusion participants gave a urine test for recent drug 
use and pregnancy, and carried out a breathalyser test for recent alcohol use.  
 
 
Twenty healthy participants (4 females, mean age = 30.9±7.8 years) attended two scanning 
sessions in different days at 8:00 (LSD and placebo) at least two weeks apart in a balanced 
order, within-subjects design.  Scanning days included arterial spin labeling (ASL) and fMRI 
followed by a MEG session. LSD (75 µμg in 10 ml saline) or placebo (10 ml saline) was 
delivered as bolus injections over 2 minutes while participants were instructed to close their 
eyes and relax. Following an acclimatization period of 60 minutes inside a mock MRI scanner, 
three fMRI scans were conducted in the following order: eyes-closed resting state, rest while 
listening to music and another eyes-closed resting state session. Only results for the first 
resting state session (prior to music) are reported here 
 
The intensity of subjective effects was stable for BOLD scans. Participants carried out VAS-
style ratings after each scan by pressing buttons on a button-box (see next sub-section). The 
11 factor altered states of consciousness (ASC) questionnaire was completed at the end of 
each dosing day. Here we focused on the VAS ratings, since they were specific to the time of 
fMRI acquisition and do not rely on retrospective evaluation of the experience, like the ASC 
questionnaire (moreover, it would have been impractical to have completed the ASC during 
scanning, as it contains 94 items, and none of them directly refers to the experience of “ego-
dissolution”). In particular, we assessed correlations with the intensity of ego-dissolution 
experienced by the participants. All participants reported closed-eye visual hallucinations and 
marked changes in consciousness under LSD.  
 
VAS items 
 
The scale for the VAS items ranged from 0 to 20. Items were phrased as follows:  
 
1) “Please rate the intensity of the drug effects during the last scan”, with a bottom anchor of 
“no effects”, a mid-point anchor of “moderately intense effects” and a top anchor of “extremely 
intense effects”; 
 
2) “With eyes closed, I saw patterns and colours”, with a bottom anchor of “no more than 
usual” and a top anchor of “much more than usual”;  
 
3) “With eyes closed, I saw complex visual imagery”, with the same anchors as item 2; 
 
4) “How positive was your mood for the last scan?”, with the same anchors as item 2, plus a 
mid-point anchor of “somewhat more than usual”; 
 
5) “I experienced a dissolving of my self or ego”, with the same anchors as item 2;  
 
6) “Please rate your general level of emotional arousal for the last scan”, with a bottom 
anchor of “not at all emotionally aroused”, a mid-point anchor of “moderately emotionally 
aroused” and a top anchor of “extremely emotionally aroused”.  
 
ASC items 
 
As part of the ASC questionnaire the participants were asked to rate the intensity of the 
following items: 
 
1) Experience of unity 
2) Spiritual experience 
3) Blissful state 
4) Insightfulness 
5) Disembodiment 
6) Impaired control and cognition 
7) Anxiety 
8) Complex imagery 
9) Elementary imagery 
10) Audio-visual synesthesia 
11) Changed meaning of percepts 
 
 
Anatomical Scans 
 
Imaging was performed on a 3T GE HDx system. These were 3D fast spoiled gradient echo 
scans in an axial orientation, with field of view = 256 × 256 × 192 and matrix = 256 × 256 × 
192 to yield 1mm isotropic voxel resolution. TR/TE = 7.9/3.0ms; inversion time = 450ms; flip 
angle = 20°. 
  
fMRI Data Acquisition 
 
BOLD fMRI data was acquired in two sessions using a gradient echo planar imaging 
sequence, TR/TE = 2000/35ms, field-of-view = 220mm, 64 × 64 acquisition matrix, parallel 
acceleration factor = 2, 90° flip angle. Thirty-five oblique axial slices were acquired in an 
interleaved fashion, each 3.4mm thick with zero slice gap (3.4mm isotropic voxels).  The 
length of the BOLD scan was 7:20 minutes.  
 
fMRI data preprocessing  
 
Resting state fMRI data was analyzed using FSL [S2], AFNI [S3], Freesurfer [S4] and ANTs 
[S5]. Of the total 20 subjects scanned, one subject did not complete the BOLD scans and four 
subjects were discarded due to high levels of head movement – as measured with framewise 
displacement (FD) [S6] - between LSD and placebo (difference in mean FD = 0.351±0.397).  
  
The following preprocessing stages were performed to the remaining 15 subjects: removing 
the first three volumes; despiking (3dDespike, AFNI); slice time correction (3dTshift, AFNI); 
motion correction (3dvolreg, AFNI) by registering each volume to the volume most similar, in 
the least squares sense, to all others (in-house code); brain extraction (BET, FSL); rigid body 
registration to anatomical scans (twelve subjects with FSL’s BBR, one subject with 
Freesurfer’s bbregister and two subjects manually); non-linear registration to 2mm MNI brain 
(Symmetric Normalization (SyN), ANTs); scrubbing [S7] using an FD threshold of 0.4  (the 
mean percentage of volumes scrubbed for placebo and LSD was 0.3±0.8% and 1.8±2.4%, 
respectively. The maximum number of scrubbed volumes per scanning session was 7.8%). 
Scrubbed volumes were replaced with the mean of the surrounding volumes. Further 
preprocessing included spatial smoothing (FWHM) of 6mm (3dBlurInMask, AFNI); bandpass 
filtering between 0.01 to 0.08 Hz (3dFourier, AFNI); linear and quadratic detrending 
(3dDetrend, AFNI); regressing out 9 nuisance regressors: out of these 6 were motion related 
(3 translations, 3 rotations) and 3 were anatomical (not smoothed). The anatomical nuisance 
regressors were: ventricles (Freesurfer, eroded in 2mm space); draining veins (DV) (FSL’s 
CSF minus Freesurfer’s Ventricles, eroded in 1mm space); and, local white matter (WM) 
(FSL’s WM minus Freesurfer’s subcortical grey matter (GM) structures, eroded in 2mm 
space. AFNI’s 3dLocalstat was used to calculate the mean local WM time series for each 
voxel (using a 25mm radius sphere centered on each voxel) [S8] 
 
Motion  
 
After discarding four subjects due to head motion, fifteen subjects were left for the BOLD 
analysis. The difference in motion for these subjects was still significant (mean FD of placebo 
= 0.076±0.036, mean FD of LSD = 0.12±0.05, p=0.0005). RSFC analysis is very sensitive to 
head motion [S7] and therefore special consideration was put to control for motion. More 
detail about the dedicated preprocessing steps we performed to reduce motion artifacts and 
other sources of noise is provided below. Despiking has been shown to improve motion 
correction and create more accurate FD values . The lowpass filter of 0.08 Hz has been 
shown to perform well in removing high frequency motion [S11]. We covaried out six motion 
regressors; this is because using more than six regressors (e.g., Friston’s 24) is likely to be 
redundant and even remove real neural signal [S12]. Using anatomical regressors is also a 
common step to clean noise. In our pipeline instead of using global WM regressors, we used 
local WM which has been suggested to preform better than using the global WM [S13]. It is 
suggested that head movement changes RSFC results in a distance dependant matter [S6]. 
Therefore, as a quality control step, at the end of the preprocessing, we plotted cloud plots to 
look for correlation between inter-node euclidian distance and FD-RSFC correlation across 
subjects. In some cases in which motion is affecting the results, proximal nodes will have high 
FD-RSFC correlations and distal nodes will have low FD-RSFC correlations. This would result 
in a negative correlation between distance and FD-RSFC correlation. In our data this 
correlation was very close to zero for both placebo and LSD suggesting that preprocessing 
successfully controlled for distance-related motion artifacts.  
 
As a final control for motion artifacts we correlated the difference in FCD values (LSD minus 
placebo) against the difference in FC (LSD minus placebo) across all 15 participants and the 
401 regions of interest. Only 5 regions revealed a significant (uncorrected) p-value (p values 
= 0.0329, 0.0250, 0.0287, 0.0347, 0.0439), with none surviving correction for multiple 
comparisons. Furthermore, we did not observe significant FCD differences in these 5 ROI 
between the LSD and placebo conditions (corrected p values for the FCD comparison in the 5 
ROIs: 0.1845, 0.2099, 0.1379, 0.1827, 0.0906). The same computation was performed for the 
time series of individual realignment parameters (three translations and three rotations), with 
null findings in all cases except translations along the x-axis. In this case only 3 ROIs 
presented significant differences between groups, but none were located among those where 
we observed differences in FCD. 
 
Functional connectivity density and seed correlation 
 
To compute the functional connectivity density (FCD) we first extracted the average BOLD 
signal from each of the 401 ROIs. Then, we computed the linear correlation (functional 
connectivity) between each one of the (401! − 401) 2  pairs of ROIs, resulting in a correlation 
matrix C!" having in its i,j the functional connectivity between the i-th and j-th ROIs. The FCD 
of the k-th ROI is defined as the average of C!" with respect to index j, i.e. !! C!"!!!!    (where n 
equals the total number of ROIs, in this case n=401). 
 
Seed correlation was computed by extracting the average BOLD signal from each of four 
masks based on significant FCD increases under LSD (frontal, parietal, precuneal and 
thalamic masks). Then, for all 401 ROIs we computed the linear correlation between its 
averaged BOLD signal and the signal from the mask, and assigned the resulting correlation 
value to the ROI. This resulted in a spatial map of correlations with the seed. 
 
Modularity of functional networks 
 
To compute the modularity of functional networks we first derived the binary adjacency matrix A!" from the weighted correlation matrix C!". This was done by thresholding the correlation 
matrix so that A!" = 1  if C!" >   ρ  and A!" = 0  otherwise. The threshold ρ  was selected to 
achieve a fixed value of link density, defined as the number of connections present in the 
network over the total number of possible connections (i.e. !!! A!"!!"!! ). It is important to 
compare binary networks with the same link density, thus guaranteeing changes are driven 
by the topological re-organization of connections between conditions and not by the total 
number of connections. The link densities under study ranged from 0.01 to 0.5; following 
previous work (e.g. [S14]) the upper limit prevents the construction of excessively connected 
networks. 
 
The intuition behind modules is that of a group of nodes having denser within-group 
connections in comparison to between-group connections (i.e. connections with other 
modules). The modular structure of a network can be obtained by maximizing the modularity 
Q, which estimates the difference between the number of intra-module links and the expected 
number (for the same partition) in a random network of the same size [S15]. Given a certain 
partition of the nodes into non-overlapping subsets, the modularity associated with this 
partition with this partition is defined as, 
 Q =    12L δ(i, j) A!" − k!k!2L!,!  
 
The sum runs over all network nodes, L is the total number of links A!"!!!! , k! = A!"!!!!  is the 
degree of the i-th node (i.e. number of links attached to the node) and δ i, j = 1 if the i-th and 
j-th nodes belong to the same subset in the partition and 0 otherwise. We computed the 
modularity of networks by keeping the maximal value obtained after 500 iterations of the 
Louvain algorithm as implemented in the Brain Connectivity Toolbox  
(https://sites.google.com/site/bctnet/) [S16]. 
 
Rich club coefficient 
 
The rich club coefficient Φ(k) is computed by dividing the number of links present between all 
nodes with degree higher than k by the maximum possible number of links between them. 
The rich club coefficient is normalized by the same metric computed after degree-preserving 
randomization of the network. We computed Φ(k) using the algorithms provided in the Brain 
Connectivity Toolbox (https://sites.google.com/site/bctnet/) [S16]. 
 
Resting State Networks (RSN) 
 
RSNs were obtained using Independent Component Analysis (ICA) on scans from the Human 
Connectome Project (HCP) [S17]. All of the scans were preprocessed as part of the HCP 
[S18]. Two BOLD resting state scans (with opposite direction of phase encoding gradient) for 
35 subjects were used in this analysis. Each scan was 14:33 minute long 
(TR/TE=720/33.2ms, 2mm isotropic voxels). All scans were bandpassed using the same filter 
as our BOLD scans (0.01 to 0.08 Hz). FSL’s MELODIC was used to extract the ICA 
components which were then visually identified [S19]. 
 
 
Testing the significance of the spatial overlap between networks 
 
The overlap was determined by comparing the percentage of voxels in the networks included 
in the FCD/seed correlation difference maps to the same numbers obtained from 500 
instances of spatial randomisation of the networks (preserving the first-order statistics of the 
images). Spatial randomization was performed by phase randomization on the frequency 
space; i.e. applying a Fast Fourier Transform to the 3D volumes, randomizing phases and 
then back-transforming to the spatial domain. Empirical p-values were derived from the 
number of instances in which the overlap with the spatially randomised networks was higher 
than the overlap computed using the real RSN. 
 
Statistical testing 
 
In all cases we compared the LSD and placebo conditions using paired t-tests.  
We applied FDR to control for the rate of false positives when performing one test per ROI 
(n=401). This comprised the results presented in Fig. 1C, Fig. 2A, Fig. 3, Fig. 4C and Fig. S1. 
When the number of comparisons was smaller (e.g. one test per RSN, n=8) we used the 
Bonferroni correction instead. This comprised the results presented in Fig. 1D and Fig. S2. 
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